ARCHIVES

In Brief: Reorganization Package Wending Its Way Through The Bureaucracy; FDA Seeks Names for Committee

This article is from The Cancer Letter archive.

Vol. 05 No. 48 | November 30, 1979

Download PDF Visit The Full Archive

Related Articles

John Durant Names ASCO Executive NP; A New Position, New Voice In Washington

December 2, 1994

Shingleton To Retire As Director Of Duke Comprehensive Center

July 10, 1981

Book Offers Info For Women Considering Ovary Removal

November 24, 2006

NCI Implements Changes To Speed Up New Drug Development; compounds In Pipeline Listed

July 9, 1976

Obey Surprises Everyone, Including Himself, And Plugs For More Money For NCI, NHLBI

March 7, 1980

FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March.

January 21, 2005